Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

76.000
+2.2503.05%
Volume:2.57M
Turnover:192.12M
Market Cap:42.83B
PE:50.39
High:76.200
Open:73.800
Low:72.600
Close:73.750
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:1.30
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.508
ROE:109.10%
ROA:39.01%
PB:4.41
PE(LYR):50.39
PS:4.58

Loading ...

REMEGEN issues supplemental disclosure after delayed reporting of seven wealth-management product purchases

Bulletin Express
·
May 19

REMEGEN Allocates Additional 35 Million Yuan to Huatai Securities Wealth Management Products

Stock News
·
May 19

RemeGen Invests in Wealth Management Products

MT Newswires Live
·
May 15

REMEGEN Allocates Idle Capital to Huatai Securities Financial Products

Stock News
·
May 15

RemeGen Allocates RMB 453.00 Million of Idle Cash to Low-to-Medium-Risk Wealth Management Products at Huatai Securities

Bulletin Express
·
May 15

RemeGen Allocates US$70.00 Million of Idle Funds to OCBC “Zeng Li” Structured Deposit

Bulletin Express
·
May 14

RemeGen Invests $70 Million in Financial Product from OCBC

Stock News
·
May 14

RemeGen Announces Acquisition of 1.43 Billion Yuan in Bank Wealth Management Products

Stock News
·
May 13

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

Stock Track | REMEGEN Plummets 5.12% Intraday on Lock-up Expiry Fears, Weak Earnings, and Sector Weakness

Stock Track
·
May 11

Stock Track | REMEGEN Plummets 6.51% Intraday on Sharp Q1 Profit Decline and Biotech Sector Weakness

Stock Track
·
May 04

RemeGen Q1 Profit Of ¥328m Revives Bullish Narratives On Biotech Turnaround

Simply Wall St.
·
Apr 29

RemeGen Swings to Profit in Q1 2026

MT Newswires Live
·
Apr 29

REMEGEN Turns Profitable in Q1 2026 on 24.8% Sales Growth and Sharply Lower R&D Spend

Bulletin Express
·
Apr 28

RemeGen 2025 ESG Report: Energy Intensity Cut by 49%, R&D Investment Reaches RMB1.22 Billion

Bulletin Express
·
Apr 28

荣昌生物2025年实现业绩显著扭转 净利达7.10亿元 营收同比增长89.5%

Bulletin Express
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

Huitianfu Fund Increases Stake in REMEGEN by 79,000 Shares at HK$113.78 Per Share

Stock News
·
Apr 24

Biopharma Stocks Slide Across Board as Oil Prices Squeeze Rate Cut Prospects

Stock News
·
Apr 23

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23